
BW Valuation
Babcock & Wilcox Enterprises Inc
- Overview
- Forecast
- Valuation
BW Relative Valuation
BW's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BW is overvalued; if below, it's undervalued.
Historical Valuation
Babcock & Wilcox Enterprises Inc (BW) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.06 is considered Undervalued compared with the five-year average of 0.45. The fair price of Babcock & Wilcox Enterprises Inc (BW) is between 2.73 to 6.30 according to relative valuation methord. Compared to the current price of 0.46 USD , Babcock & Wilcox Enterprises Inc is Undervalued By 83.00%.
Relative Value
Fair Zone
2.73-6.30
Current Price:0.46
83.00%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-0.15
P/B
Median3y
-16.50
Median5y
-22.68
-286.62
FCF Yield
Median3y
-40.70
Median5y
-37.54
Competitors Valuation Multiple
The average P/S ratio for BW's competitors is 0.97, providing a benchmark for relative valuation. Babcock & Wilcox Enterprises Inc Corp (BW) exhibits a P/S ratio of 0.06, which is -93.85% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

SVC
Service Properties Trust
1.960
USD
+3.16%

SMC
Summit Midstream Corp
28.080
USD
+3.05%

PACB
Pacific Biosciences of California Inc
1.130
USD
+1.80%

KROS
Keros Therapeutics Inc
14.640
USD
+0.48%

API
Agora Inc
3.410
USD
+0.29%

FC
Franklin Covey Co
21.190
USD
+2.91%

ALNT
Allient Inc
22.470
USD
+3.88%

MREO
Mereo BioPharma Group PLC
2.675
USD
+2.88%

SIGA
SIGA Technologies Inc
5.620
USD
+3.50%

CVRX
CVRx Inc
7.940
USD
+8.92%
FAQ

Is Babcock & Wilcox Enterprises Inc (BW) currently overvalued or undervalued?
Babcock & Wilcox Enterprises Inc (BW) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.06 is considered Undervalued compared with the five-year average of 0.45. The fair price of Babcock & Wilcox Enterprises Inc (BW) is between 2.73 to 6.30 according to relative valuation methord. Compared to the current price of 0.46 USD , Babcock & Wilcox Enterprises Inc is Undervalued By 83.00% .

What is Babcock & Wilcox Enterprises Inc (BW) fair value?

How does BW's valuation metrics compare to the industry average?

What is the current P/B ratio for Babcock & Wilcox Enterprises Inc (BW) as of May 02 2025?

What is the current FCF Yield for Babcock & Wilcox Enterprises Inc (BW) as of May 02 2025?

What is the current Forward P/E ratio for Babcock & Wilcox Enterprises Inc (BW) as of May 02 2025?
